trending Market Intelligence /marketintelligence/en/news-insights/trending/QYDFqh3ghHUsT2GJfQA9rg2 content esgSubNav
In This List

Quidel adds director

Blog

Baird Research is Now Exclusively Available in S&P Global’s Aftermarket Research Collection

Blog

Japan M&A By the Numbers: Q4 2023

Blog

Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity


Quidel adds director

Quidel Corp. appointed Edward Michael to the board.

Michael serves as the co-founder and managing partner of LionBird (Ventures) Ltd., a venture capital firm. In addition, he is a board member of NeuMoDx Molecular Inc., a molecular diagnostics company. Michael was also executive vice president of diagnostic products at Abbott Laboratories.

Quidel also expanded the board size from eight to nine directors.

San Diego-based Quidel develops, manufactures and markets diagnostic testing solutions for applications in infectious diseases, cardiology, thyroid, women's and general health, eye health, gastrointestinal diseases, and toxicology.